- Home
- Publications
- Publication Search
- Publication Details
Title
Non-kinase targets of protein kinase inhibitors
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 16, Issue 6, Pages 424-440
Publisher
Springer Nature
Online
2017-03-10
DOI
10.1038/nrd.2016.266
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors
- (2016) Susan Klaeger et al. ACS Chemical Biology
- Validation and development of MTH1 inhibitors for treatment of cancer
- (2016) U. Warpman Berglund et al. ANNALS OF ONCOLOGY
- Identification of potent and selective MTH1 inhibitors
- (2016) Alessia Petrocchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling
- (2016) Sai Krishna Athuluri-Divakar et al. CELL
- Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
- (2016) Peng Wu et al. DRUG DISCOVERY TODAY
- Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants
- (2016) Hengmiao Cheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival
- (2016) Jason G. Kettle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Feeling Nature’s PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)
- (2016) Jonathan B. Baell JOURNAL OF NATURAL PRODUCTS
- The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia
- (2016) Gabriela Brumatti et al. Science Translational Medicine
- Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype
- (2016) Feimeng Zheng et al. Nature Communications
- Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival
- (2016) Tatsuro Kawamura et al. Scientific Reports
- Image-based compound profiling reveals a dual inhibitor of tyrosine kinase and microtubule polymerization
- (2016) Kenji Tanabe Scientific Reports
- CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A
- (2016) Jennifer Chu et al. Cell Reports
- Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2
- (2016) Matej Janeček et al. Scientific Reports
- Parkinsonian toxin-induced oxidative stress inhibits basal autophagy in astrocytes via NQO2/quinone oxidoreductase 2: Implications for neuroprotection
- (2015) Elzbieta Janda et al. Autophagy
- The problem of pyridinyl imidazole class inhibitors of MAPK14/p38α and MAPK11/p38β in autophagy research
- (2015) Manoj B Menon et al. Autophagy
- Going for broke: targeting the human cancer pseudokinome
- (2015) Fiona P. Bailey et al. BIOCHEMICAL JOURNAL
- Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy
- (2015) Elias E. Stratikopoulos et al. CANCER CELL
- A Kinase-Independent Role for EGF Receptor in Autophagy Initiation
- (2015) Xiaojun Tan et al. CELL
- Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes
- (2015) Stuart L. Schreiber et al. CELL
- Activity-Based Protein Profiling: Recent Advances in Probe Development and Applications
- (2015) Pengyu Yang et al. CHEMBIOCHEM
- Identifying Drug-Target Selectivity of Small-Molecule CRM1/XPO1 Inhibitors by CRISPR/Cas9 Genome Editing
- (2015) Jasper E. Neggers et al. CHEMISTRY & BIOLOGY
- Extending kinome coverage by analysis of kinase inhibitor broad profiling data
- (2015) Edgar Jacoby et al. DRUG DISCOVERY TODAY
- Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery
- (2015) Yuxi Wang et al. FEBS Journal
- Methyl 3-((6-Methoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)amino)benzoate (GN39482) as a Tubulin Polymerization Inhibitor Identified by MorphoBase and ChemProteoBase Profiling Methods
- (2015) Hidemitsu Minegishi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative Activity
- (2015) Davide Carta et al. JOURNAL OF MEDICINAL CHEMISTRY
- Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus
- (2015) Federico Cappuzzo et al. LUNG CANCER
- Comprehensive characterization of the Published Kinase Inhibitor Set
- (2015) Jonathan M Elkins et al. NATURE BIOTECHNOLOGY
- Know your target, know your molecule
- (2015) Mark E Bunnage et al. Nature Chemical Biology
- CRISPR-Cas9–based target validation for p53-reactivating model compounds
- (2015) Michael Wanzel et al. Nature Chemical Biology
- Correlating chemical sensitivity and basal gene expression reveals mechanism of action
- (2015) Matthew G Rees et al. Nature Chemical Biology
- The promise and peril of chemical probes
- (2015) Cheryl H Arrowsmith et al. Nature Chemical Biology
- The diverse role of RIP kinases in necroptosis and inflammation
- (2015) John Silke et al. NATURE IMMUNOLOGY
- Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling
- (2015) Kilian V M Huber et al. NATURE METHODS
- Thermal proteome profiling monitors ligand interactions with cellular membrane proteins
- (2015) Friedrich B M Reinhard et al. NATURE METHODS
- Tackling reproducibility in academic preclinical drug discovery
- (2015) Stephen V. Frye et al. NATURE REVIEWS DRUG DISCOVERY
- DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications
- (2015) Ramzi Abbassi et al. PHARMACOLOGY & THERAPEUTICS
- Beating the odds: BETs in disease
- (2015) Chen-Yi Wang et al. TRENDS IN BIOCHEMICAL SCIENCES
- RIPK1 and RIPK3: critical regulators of inflammation and cell death
- (2015) Kim Newton TRENDS IN CELL BIOLOGY
- Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization
- (2015) S Mahale et al. Cell Death & Disease
- Kinase-independent role for CRAF-driving tumour radioresistance via CHK2
- (2015) Sunil J. Advani et al. Nature Communications
- Fluid shear triggers microvilli formation via mechanosensitive activation of TRPV6
- (2015) Shigenori Miura et al. Nature Communications
- Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
- (2015) B. Seashore-Ludlow et al. Cancer Discovery
- Assessing the Efficacy of Mdm2/Mdm4-Inhibiting Stapled Peptides Using Cellular Thermal Shift Assays
- (2015) Ban Xiong Tan et al. Scientific Reports
- Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
- (2015) Timothy J. Stuhlmiller et al. Cell Reports
- ATP-Mediated Kinome Selectivity: The Missing Link in Understanding the Contribution of Individual JAK Kinase Isoforms to Cellular Signaling
- (2014) Atli Thorarensen et al. ACS Chemical Biology
- Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
- (2014) Stuart W. J. Ember et al. ACS Chemical Biology
- MAPK14/p38α-dependent modulation of glucose metabolism affects ROS levels and autophagy during starvation
- (2014) Enrico Desideri et al. Autophagy
- Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
- (2014) Jacob R. Haling et al. CANCER CELL
- Chemical biology approaches to target validation in cancer
- (2014) Julian Blagg et al. CURRENT OPINION IN PHARMACOLOGY
- Cutting Edge: RIPK1 Kinase Inactive Mice Are Viable and Protected from TNF-Induced Necroptosis In Vivo
- (2014) Apostolos Polykratis et al. JOURNAL OF IMMUNOLOGY
- Discovery of Biarylaminoquinazolines as Novel Tubulin Polymerization Inhibitors
- (2014) Giovanni Marzaro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tivantinib (ARQ 197) Exhibits Antitumor Activity by Directly Interacting with Tubulin and Overcomes ABC Transporter-Mediated Drug Resistance
- (2014) A. Aoyama et al. MOLECULAR CANCER THERAPEUTICS
- RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
- (2014) Pratyusha Mandal et al. MOLECULAR CELL
- Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy
- (2014) Kilian V. M. Huber et al. NATURE
- MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
- (2014) Helge Gad et al. NATURE
- Chemistry: Chemical con artists foil drug discovery
- (2014) Jonathan Baell et al. NATURE
- RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis
- (2014) Marius Dannappel et al. NATURE
- DNA sequencing and CRISPR-Cas9 gene editing for target validation in mammalian cells
- (2014) Yegor Smurnyy et al. Nature Chemical Biology
- Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
- (2014) Pietro Ciceri et al. Nature Chemical Biology
- DrugTargetSeqR: a genomics- and CRISPR-Cas9–based method to analyze drug targets
- (2014) Corynn Kasap et al. Nature Chemical Biology
- A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
- (2014) Bryan R Lanning et al. Nature Chemical Biology
- The cellular thermal shift assay for evaluating drug target interactions in cells
- (2014) Rozbeh Jafari et al. Nature Protocols
- A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1
- (2014) T. Justin Rettenmaier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death
- (2014) Joanne M. Hildebrand et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tracking cancer drugs in living cells by thermal profiling of the proteome
- (2014) M. M. Savitski et al. SCIENCE
- Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis
- (2014) K. Newton et al. SCIENCE
- A kinase-independent function of AKT promotes cancer cell survival
- (2014) Igor Vivanco et al. eLife
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
- (2014) Scott J Dixon et al. eLife
- Microtubules and Their Role in Cellular Stress in Cancer
- (2014) Amelia L. Parker et al. Frontiers in Oncology
- The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains
- (2013) Antje Dittmann et al. ACS Chemical Biology
- Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains
- (2013) Mathew P. Martin et al. ACS Chemical Biology
- Comparison of Cancer Cell Survival Triggered by Microtubule Damage after Turning Dyrk1B Kinase On and Off
- (2013) Liwen Li et al. ACS Chemical Biology
- Dawn of the dead: protein pseudokinases signal new adventures in cell biology
- (2013) Patrick A. Eyers et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition
- (2013) R. Katayama et al. CANCER RESEARCH
- An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
- (2013) Amrita Basu et al. CELL
- Tivantinib (ARQ197) Displays Cytotoxic Activity That Is Independent of Its Ability to Bind MET
- (2013) C. Basilico et al. CLINICAL CANCER RESEARCH
- NRH:Quinone Oxidoreductase 2 (NQO2) Protein Competes with the 20 S Proteasome to Stabilize Transcription Factor CCAAT Enhancer-binding Protein α (C/EBPα), Leading to Protection against γ Radiation-induced Myeloproliferative Disease
- (2013) Junkang Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selective 3-Phosphoinositide-Dependent Kinase 1 (PDK1) Inhibitors: Dissecting the Function and Pharmacology of PDK1
- (2013) Jesús R. Medina JOURNAL OF MEDICINAL CHEMISTRY
- BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms
- (2013) B S Wyspiańska et al. LEUKEMIA
- Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis
- (2013) Erik C Hett et al. Nature Chemical Biology
- Target identification and mechanism of action in chemical biology and drug discovery
- (2013) Monica Schenone et al. Nature Chemical Biology
- Target validation using chemical probes
- (2013) Mark E Bunnage et al. Nature Chemical Biology
- Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance
- (2013) P. A. Schwartz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Small molecule sensitization to TRAIL is mediated via nuclear localization, phosphorylation and inhibition of chaperone activity of Hsp27
- (2013) G Mellier et al. Cell Death & Disease
- MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy
- (2012) Salome Paillas et al. Autophagy
- Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors
- (2012) Ayaz Najafov et al. BIOCHEMICAL JOURNAL
- The Kynurenine Pathway in Brain Tumor Pathogenesis
- (2012) S. Adams et al. CANCER RESEARCH
- Substrate-Selective Inhibition of Protein Kinase PDK1 by Small Compounds that Bind to the PIF-Pocket Allosteric Docking Site
- (2012) Katrien Busschots et al. CHEMISTRY & BIOLOGY
- Indoleamine 2,3-dioxygenase: From catalyst to signaling function
- (2012) Francesca Fallarino et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Chemistry-based functional proteomics for drug target deconvolution
- (2012) Kui Wang et al. Expert Review of Proteomics
- Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
- (2012) Tjeerd Barf et al. JOURNAL OF MEDICINAL CHEMISTRY
- Using transcriptome sequencing to identify mechanisms of drug action and resistance
- (2012) Sarah A Wacker et al. Nature Chemical Biology
- Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
- (2012) Joanne Bowes et al. NATURE REVIEWS DRUG DISCOVERY
- Kinase-independent function of checkpoint kinase 1 (Chk1) in the replication of damaged DNA
- (2012) J. Speroni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain
- (2012) B. N. Devaiah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models
- (2012) N Takahashi et al. Cell Death & Disease
- The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
- (2011) Arvin C. Dar et al. Annual Review of Biochemistry
- Induction of autophagy in hepatocellular carcinoma cells by SB203580 requires activation of AMPK and DAPK but not p38 MAPK
- (2011) Haitao Zhang et al. APOPTOSIS
- PDK1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models
- (2011) K. Ellwood-Yen et al. CANCER RESEARCH
- The secret life of kinases: functions beyond catalysis
- (2011) Jens Rauch et al. Cell Communication and Signaling
- High-Throughput Kinase Profiling: A More Efficient Approach toward the Discovery of New Kinase Inhibitors
- (2011) Chandrasekhar V. Miduturu et al. CHEMISTRY & BIOLOGY
- Discovery of a Novel Mode of Protein Kinase Inhibition Characterized by the Mechanism of Inhibition of Human Mesenchymal-epithelial Transition Factor (c-Met) Protein Autophosphorylation by ARQ 197
- (2011) Sudharshan Eathiraj et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- A MEK-independent role for CRAF in mitosis and tumor progression
- (2011) Ainhoa Mielgo et al. NATURE MEDICINE
- Mitosis is not a key target of microtubule agents in patient tumors
- (2011) Edina Komlodi-Pasztor et al. Nature Reviews Clinical Oncology
- P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance
- (2011) M A de la Cruz-Morcillo et al. ONCOGENE
- IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation
- (2011) J K Cheong et al. ONCOGENE
- SB202190-Induced Cell Type-Specific Vacuole Formation and Defective Autophagy Do Not Depend on p38 MAP Kinase Inhibition
- (2011) Manoj B. Menon et al. PLoS One
- TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells
- (2010) Vijay Ramakrishnan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Fluorescence polarization binding assay to develop inhibitors of inactive p38α mitogen-activated protein kinase
- (2010) Lenka Munoz et al. ANALYTICAL BIOCHEMISTRY
- EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity
- (2010) Hu Zhu et al. CANCER LETTERS
- Application of Proteomic Profiling Based on 2D-DIGE for Classification of Compounds According to the Mechanism of Action
- (2010) Makoto Muroi et al. CHEMISTRY & BIOLOGY
- Enhanced Indoleamine 2,3‐Dioxygenase Activity in Patients with Severe Sepsis and Septic Shock
- (2010) Pierre Tattevin et al. JOURNAL OF INFECTIOUS DISEASES
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Benzothiophene Inhibitor of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Inhibits Tumor Necrosis Factor Production and Has Oral Anti-Inflammatory Efficacy in Acute and Chronic Models of Inflammation
- (2010) R. J. Mourey et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
- (2010) N. Munshi et al. MOLECULAR CANCER THERAPEUTICS
- Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
- (2010) David Parry et al. MOLECULAR CANCER THERAPEUTICS
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- A genetically selective inhibitor demonstrates a function for the kinase Zap70 in regulatory T cells independent of its catalytic activity
- (2010) Byron B Au-Yeung et al. NATURE IMMUNOLOGY
- Microtubule-binding agents: a dynamic field of cancer therapeutics
- (2010) Charles Dumontet et al. NATURE REVIEWS DRUG DISCOVERY
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
- (2010) L. A. Honigberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LY303511 Enhances TRAIL Sensitivity of SHEP-1 Neuroblastoma Cells via Hydrogen Peroxide-Mediated Mitogen-Activated Protein Kinase Activation and Up-regulation of Death Receptors
- (2009) K. Shenoy et al. CANCER RESEARCH
- Coordinated regulation of autophagy by p38α MAPK through mAtg9 and p38IP
- (2009) Jemma L Webber et al. EMBO JOURNAL
- Blockade of Indoleamine 2,3-Dioxygenase Protects Mice against Lipopolysaccharide-Induced Endotoxin Shock
- (2009) I. D. Jung et al. JOURNAL OF IMMUNOLOGY
- Selective Inhibition of Casein Kinase 1 Minimally Alters Circadian Clock Period
- (2009) K. M. Walton et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Erythropoietic protoporphyria
- (2009) Mario Lecha et al. Orphanet Journal of Rare Diseases
- The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2)
- (2009) Jonathan A Winger et al. BMC STRUCTURAL BIOLOGY
- Survival of Cancer Cells Is Maintained by EGFR Independent of Its Kinase Activity
- (2008) Zhang Weihua et al. CANCER CELL
- Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera
- (2008) Gerlinde Wernig et al. CANCER CELL
- Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo
- (2008) C Brockschmidt et al. GUT
- Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors
- (2008) P. Ross-Macdonald et al. MOLECULAR CANCER THERAPEUTICS
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started